国产精品ⅴ无码大片在线看,激情影院内射美女,动物与人性生活一区二区三区性生活激情视频,久久久久免费毛a片免费一瓶梅



  • 尊龍凱時(shí)·(中國(guó)區(qū))人生就是搏!

    EN
    ×
    EN
    • 業(yè)務(wù)咨詢

      中國(guó):

      Email: marketing@www.msjidi.com

      業(yè)務(wù)咨詢專線:400-780-8018

      (僅限服務(wù)咨詢,其他事宜請(qǐng)撥打川沙總部電話)

      川沙總部電話: +86 (21) 5859-1500

      海外:

      +1(781)535-1428(U.S.)

      0044 7790 816 954 (Europe)

      Email:marketing@medicilon.com

    在線留言×
    Customer Center
    客戶中心
    成功案例 科研速遞 下載中心 客戶評(píng)價(jià) 合作伙伴 知識(shí)產(chǎn)權(quán)保護(hù)
    首頁(yè) 客戶中心 尊龍凱時(shí)助力文獻(xiàn)

    藥物發(fā)現(xiàn)中的挑戰(zhàn)之一是識(shí)別高質(zhì)量的先導(dǎo)化合物。此研究中PK結(jié)果表明L12可作為針對(duì)PDE5的先導(dǎo)化合物,進(jìn)一步研究和開發(fā)。L12的PK分析通過(guò)尊龍凱時(shí)進(jìn)行

    2023-07-06
    |
    訪問(wèn)量:

    Scaffold hopping refers to computer-aided screening for active compounds with different structures against the same receptor to enrich privileged scaffolds, which is a topic of high interest in organic and medicinal chemistry. One of the biggest challenges in drug discovery is to identify high-quality hit and lead compounds. Lead L12 had an IC50 of 8.7 nM and exhibited a different binding pattern in its crystal structure with PDE5 from the famous starting drug tadalafil, and PK results indicate that L12 could be used as a promising lead for further development. Pharmacokinetic properties of L12 were analyzed by Medicilon.

    Reference:

    Deyan Wu, et al. Free energy perturbation (FEP)-guided scaffold hopping. Acta Pharm Sin B. 2022 Mar;12(3):1351-1362. doi: 10.1016/j.apsb.2021.09.027. 

    相關(guān)新聞

    川沙總部

    地址: 上海市浦東新區(qū)川大路585號(hào)

    郵編: 201299

    電話: +86 (21) 5859-1500(總機(jī))

    傳真: +86 (21) 5859-6369

    業(yè)務(wù)咨詢

    中國(guó):

    Email: marketing@medicilon.com

    業(yè)務(wù)咨詢專線:400-780-8018

    (僅限服務(wù)咨詢,其他事宜請(qǐng)撥打川沙
    總部電話)

     

    海外:

    Email:?marketing@medicilon.com

    Tel: +1 (617) 888-9294(U.S.)

    Tel: 0044 7790 816 954 (Europe)

    Tel: +82 70-8269-5849 (Korea)

    Tel: +81 80-4421-6898 (Japan)

    ? 2022 上海尊龍凱時(shí)生物醫(yī)藥股份有限公司 保留所有權(quán)利 滬ICP備10216606號(hào)-3
    滬公網(wǎng)安備 31011502012909號(hào)|網(wǎng)站地圖|技術(shù)支持:集錦科技
    安全性評(píng)價(jià) 溶瘤病毒 PDX模型 IND申報(bào) AAALAC
    ×
    搜索驗(yàn)證